Vascular Disease and Surgery

Stephen Black, Bijan Modarai, Halim Yammine, et al

Watch time: 14h 30m (9 videos)

Stephen Black, Bijan Modarai, Halim Yammine, et al

Watch time: 14h 30m (9 videos)

About

Heart transplantation surgery has become the standard treatment for selected patients with end-stage heart failure. Improvements in immunosuppressant, donor procurement, surgical techniques, and post-transplant care have resulted in a substantial decrease in acute allograft rejection, which had previously significantly limited survival of heart transplant recipients.

The number of heart transplants performed worldwide over the last decade has continued to increase annually.

Current challenges include older age of both recipients and donors; an increasing number of transplants performed with mechanical circulatory support; the growing use of combined organ transplants (now more than 4% of all heart transplants); and a high proportion of sensitised patients (those with pre-formed antibodies against human leukocyte antigens, which increased the risk of organ rejection).

Articles

New Technology Focus: Smart Polymer in Vascular Surgery

Published:

18 May 2022

Citation:

Vascular & Endovascular Review 2022;5(Suppl 1):1–8.

Interventions for IVC Thrombosis

Published:

16 May 2022

Citation:

Vascular & Endovascular Review 2022;5:e04.

VBX FLEX Study Review

Published:

11 April 2022

Citation:

Vascular & Endovascular Review 2022;5:e03.

Aetiology and Therapeutic Options of Acute Subclavian Vein Thrombosis

Published:

16 March 2022

Citation:

Vascular & Endovascular Review 2022;5:e02.